$0.00
(0.00%
) Quote detailsUSD
$0.00
(0.00%
)At Close (As of Dec 9, 2025)
$1.26B
Market Cap
-
P/E Ratio
-1.73
EPS
$26.59
52 Week High
$6.92
52 Week Low
HEALTHCARE
Sector
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Xencor, Inc. is a clinical-stage biopharmaceutical company headquartered in Monrovia, California, specializing in the development of next-generation cytokine and monoclonal antibody therapies aimed at addressing unmet medical needs in oncology and autoimmune diseases. Leveraging its proprietary XmAb technology platform, Xencor seeks to enhance both the efficacy and safety profiles of its therapeutics, making strides in the increasingly competitive biopharmaceutical landscape. With a robust and diversified pipeline nearing clinical advancement, Xencor is strategically positioned to deliver innovative solutions that could substantially improve patient outcomes both domestically and internationally, making it a noteworthy entity for institutional investors.
LPTX
NVDA
WBD
ASST
VHAI
PLUG
BYND
AAL
TSLA
INTC
SOFI
CFLT
NFLX
ADAP
GRAB
BITF
BAC
PFE
MARA
T
DNN
KVUE
IRBT
WULF
CIFR
F
CLSK
KEY
VZ
APLD
HPE
RGTI
CXAI
IREN
GOOGL
HBAN
NIO
BTBT
MTSR
DVLT
RIG
AMD
RR
SOUN
MSTR
XOM
AVGO
SNAP
WMT
MRVL
VALE
QBTS
KDP
CAN
ITUB
NVTS
AGNC
NCLH
HOOD
PCG
PLTR
LPTX
NVDA
WBD
ASST
VHAI
PLUG
BYND
AAL
TSLA
INTC
SOFI
CFLT
NFLX
ADAP
GRAB
BITF
BAC
PFE
MARA
T
DNN
KVUE
IRBT
WULF
CIFR
F
CLSK
KEY
VZ
APLD
HPE
RGTI
CXAI
IREN
GOOGL
HBAN
NIO
BTBT
MTSR
DVLT
RIG
AMD
RR
SOUN
MSTR
XOM
AVGO
SNAP
WMT
MRVL
VALE
QBTS
KDP
CAN
ITUB
NVTS
AGNC
NCLH
HOOD
PCG
PLTR